Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

100 Questions and Answers about Liver Cancer
  • Language: en
  • Pages: 137

100 Questions and Answers about Liver Cancer

100 Questions & Answers About Liver Cancer is a quick and practical reference guide containing all aspects of the diagnosis and therapy of hepatocellular carcinoma (HCC), prognostic and staging systems, clinical management, molecular biology, current controversies, and future insights. Organized into a condensed, bulleted format, this concise reference offers precise and up-to-date information on the epidemiology, classification, diagnosis, treatment, and risk factors for cancers of the liver.

100 Questions & Answers About Liver Cancer
  • Language: en
  • Pages: 154

100 Questions & Answers About Liver Cancer

EMPOWER YOURSELF! Whether you're a newly diagnosed liver cancer patient, a survivor, or a friend or relative of either, this book offers help. The only text to provide the doctor's and patient's views, 100 Questions & Answers About Liver Cancer, Second Edition gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by a medical oncologist and a gastrointestinal surgeon, with actual patient commentary, this book is an invaluable resource for anyone coping with the physical and emotional turmoil of this frightening disease.

Immunotherapy of Hepatocellular Carcinoma
  • Language: en

Immunotherapy of Hepatocellular Carcinoma

  • Type: Book
  • -
  • Published: 2018-08-22
  • -
  • Publisher: Springer

In this book we provide insights into liver – cancer and immunology. Experts in the field provide an overview over fundamental immunological questions in liver cancer and tumorimmunology, which form the base for immune based approaches in HCC, which gain increasing interest in the community due to first promising results obtained in early clinical trials. Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death in the United States. Treatment options are limited. Viral hepatitis is one of the major risk factors for HCC, which represents a typical “inflammation-induced” cancer. Immune-based treatment approaches have revolutionized oncology in recent years. V...

100 Questions & Answers About Liver Cancer
  • Language: en
  • Pages: 154

100 Questions & Answers About Liver Cancer

Providing both doctor and patient perspectives, this updated edition offers authoritative answers to the most commonly asked questions about liver cancer including diagnosis, treatment, post-treatment quality of life, and coping strategies. Written by a medical oncologist and a gastrointestinal surgeon, with actual patient commentary, 100 Questions & Answers About Liver Cancer, Fourth Edition is an invaluable resource for anyone coping with the physical and emotional turmoil of this disease.

Hepatobiliary Cancer
  • Language: en
  • Pages: 502

Hepatobiliary Cancer

  • Type: Book
  • -
  • Published: 2014
  • -
  • Publisher: PMPH USA

Hepatobiliary Cancer addresses the field with contributions from talented practitioners from around the world in surgery, chemotherapy, radiation therapy, medical oncology, and integrative medicine. The text approaches these cancers by type – biliary and liver tumors – and in terms of diagnostic techniques and therapies: surgical, ablative, systemic and regional chemotherapies, biologic, and complementary. Hepatobiliary Cancer is essential reading for anyone expert in, or engaged in learning about, treating hepatobiliary cancers. Heavily illustrated with photomicrographs, photographs, drawings, and tables to support and illuminate the text, it is a concise, yet comprehensive guide to hepatobiliary cancer diagnosis and treatment.

Dx/Rx: Liver Cancer
  • Language: en
  • Pages: 167

Dx/Rx: Liver Cancer

Dx/Rx: Liver Cancer is a quick and practical reference guide containing all aspects of the diagnosis and therapy of hepatocellular carcinoma (HCC), prognostic and staging systems, clinical management, molecular biology, current controversies, and future insights. Organized into a condensed, bulleted format, this concise reference offers precise and up-to-date information on the epidemiology, classification, diagnosis, treatment, and risk factors for cancers of the liver. Presented in a handy, easy-to-read format, Dx/Rx: Liver Cancer is a must-have resource for oncologists, internists, primary care physicians, and other health care professionals on the ward or in the clinic.

Dx/Rx
  • Language: en
  • Pages: 166

Dx/Rx

None

Multidisciplinary Treatment of Hepatocellular Carcinoma
  • Language: en
  • Pages: 266

Multidisciplinary Treatment of Hepatocellular Carcinoma

It is now widely accepted that multidisciplinary collaboration and multimodality treatment approaches are important in improving the survival of patients with hepatocellular carcinoma. In this comprehensive textbook, internationally renowned experts in the field present and discuss the various strategies employed in the treatment of the disease. Up-to-date information is provided on the indications for and outcome of a range of treatment options, including surgical resection, liver transplantation, radiofrequency ablation, transarterial chemoembolization, yttrium-90 transarterial radioembolization, and systemic therapy. In addition, important background information is included on biology, pathology, staging, and imaging. This book will be particularly helpful to all professionals and trainees worldwide who have an interest in the diagnosis and treatment of hepatocellular carcinoma.

Immune Strategies for Gastrointestinal Cancer
  • Language: en
  • Pages: 291

Immune Strategies for Gastrointestinal Cancer

This book provides an overview of the available evidence surrounding immunotherapy in gastrointestinal cancers, and discusses its future place in clinical practice. Immunotherapy has celebrated some astonishing therapeutic successes in a variety of cancer types and is becoming increasingly relevant in daily clinical practice. Currently, the predominant class of immunotherapeutic drugs is the so-called checkpoint inhibitors, which disengage the physiological brakes on the immune system, enabling a more effective anti-cancer immune response. Malignancies of the gastrointestinal tract, which account for the majority of cancer cases worldwide, are a major cause of morbidity and mortality, creating an urgent need for more effective therapies. A large number of clinical trials have evaluated the efficacy of cancer immunotherapy in gastrointestinal malignancies and demonstrated its potential in certain subsets of patients. This book will appeal to a wide readership, including oncologists, health care professionals in general and biomedical scientists.

100 Questions & Answers About Cholangiocarcinoma, Gallbladder, and Bile Duct Cancers
  • Language: en
  • Pages: 161

100 Questions & Answers About Cholangiocarcinoma, Gallbladder, and Bile Duct Cancers

100 Questions & Answers About Cholangiocarcinoma, Gallbladder, and Bile Duct Cancers is a resource that empowers patients and caregivers with the information needed to navigate their treatment with realistic goals for a good quality of life and targeted long-term survivorship.